Onco Therapies Limited (OTL), the wholly-owned oncology subsidiary of Strides, has received the UK's approval for Oxaliplatin injections in strengths of 5 mg per 10 ml, 5 mg per 20 ml and 5 mg per 40 ml, Strides Arcolab said in a statement.
"The current approval is from UK and approval for the rest of the European countries is expected shortly," it added.
1889
2999
159
389
464
499
2009
3999
339
1299
2109
4199
15999
15999
9119
18199
1089
2199
5487
19199
430
999
350
999